50 million people globally have dementia, and out of all the dementia cases, Alzheimer’s Disease accounts for about 60–70% of cases, says the WHO. Alzheimer's Disease is a neurodegenerative disease...
Alzheimer's Disease Market finally witnessed the approval of standard therapy, Aducanumab, by Biogen. What impact does it hold for the future? Demographic or population ageing is a global and dominant phenomenon of the 21st century. Different geographies are experiencing population ageing at different rates. As ...
Find MoreAlzheimer's is a progressive neurological disorder associated with the degeneration of brain cells with time. As the disease progresses it causes severe impact on the memory, thinking, and overall behavior of the individual, at the later phases it becomes even challenging to perform simple day to day tasks. ...
Find MoreGene-edited T cells for diabetes treatment The Scientists at the Seattle Children's Research Institute and the Benaroya Research Institute have got a promising finding that will turn off the destructive autoimmune response in Type 1 diabetes. This comprises editing the genes of patients' T cells. The team pre...
Find MoreAlzheimer’s is a brain disease, associated with the degeneration of brain cells. It is an irreversible and progressive disease that generally affects people aged above 65 years but in very rare cases, early-onset has also been noticed in the late ’40s. The AD affects memory, reasoning and cognitive skills of the pe...
Find MoreThe ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approximately 10.9 billion. Moreover, between 2020 and 2100, the number of people ages 80 and older is expected to increase from 146 million to 881 million. ...
Find MoreThe startup focuses on glioblastoma tumors with CAR-T therapy. CAR-T technology that involves genetically modifying a patient’s immune cells to recognize and attack cancer. However, while the innovation has helped patients with certain blood malignancies, progress in solid tumors remains restricted. The scien...
Find MoreCanSino adds mRNA with Precision NanoSystems CanSino Biologics is already evaluating a recombinant coronavirus vaccine in China. However, it is adding the mRNA to COVID-19 vaccine through a licensing agreement with Precision NanoSystems. The partners will work on an mRNA nanoparticle vaccine for COVID-1...
Find MoreFlorence-based Menarini Group has announced a USD667 million acquisition of the Stemline Therapeutics, an oncology-focused company. As per the agreement, Menarini plans to help Stemline to build a strong foothold in the U.S., and will also continue the development of Elzonris, a CD123 targeted therapy. Th...
Find MoreRemdesivir of Gilead accelerates COVID-19 recovery Gilead Sciences' Remdesivir shows the first data from a placebo-controlled study. Remdesivir decreases recovery time for hospitalized COVID-19 patients by four days or 31% as published in a National Institutes of Health-sponsored study setting the drug against p...
Find MoreBK Virus Infection , a member of the polyomavirus family, is typically associated with patients who .....
Find MoreA formal medical disorder affecting approximately 10 percent of the world population is trypanophobi.....
Find MorePyelonephritis (Kidney infection) is an infection of the kidney, which is a consequence of urinary t.....
Find MoreCell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....
Find MoreReal-world evidence (RWE) is used in an exponential way to guide payment decisions and access system.....
Find MoreAsthma is a chronic disease of the air passages characterized by inflammation and narrowing of the a.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.